Close Menu

NEW YORK (GenomeWeb) – Canopy Biosciences announced today that it has acquired German cytometry startup Zellkraftwerk as part of its plans to build a wider product and service offering.

According to Canopy, the acquisition creates a "unique multi-omics" company that offers "a powerful union of genomic expertise with cutting-edge cell and tissue analysis solutions" to further help "drug development research and biomarker discovery."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.

Jun
11
Sponsored by
Roche

This webinar will overview the potential for liquid biopsy approaches to monitor therapy resistance in lung cancer.